Obermatt
See Similar Stocks →

Carlsmed

NSQ:CARL · US14280C1053
Health Care Equipment & SuppliesSmall

360

29
Profit price68
Owner Earnings Yield1
Dividend Yield1
Price/Sales32
EV / Gross Profit36
Price/Book28
Return on Capital23
Cash Return on Capital34
Return on Equity38
EBIT Margin18
Gross Profitability49
Accruals5
Owner Earnings Margin20
Sales growth98
Profit Growth10
Long-Term EPS Growth100
Reinvestment28
Price momentum54
Debt load65
Refinancing72
Debt Payback1
Liquidity9
Analyst ratings81
Opinion Changes50
Price Target Upside57
Market mood5
Value Creation8/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Carlsmed clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded2018
Employees132
Websitecarlsmed.com
ISINUS14280C1053
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Biomedical EngineeringMachine LearningArtificial IntelligenceOrthopaedicsSurgeryAnalyticsHealth CareMedical Device

Description

Carlsmed, Inc. operates as a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a focus on becoming the standard of care for spine fusion surgery. The company’s mission is to improve outcomes…

Analysis

Weak and unloved

Carlsmed, Inc. scores below average on quality and is priced accordingly, a low-conviction position in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is adequate. The company scores 8/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
29
2026

All-time high

47

Mar 2026

All-time low

29

Jun 2026

Average rank

38

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
32
—
—
—
Price/Earnings
91
—
—
—
Price/Book
28
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
42
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Carlsmed with its peers
Butterfly Network
NYQ:BFLY
23
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
AVITA Medical
NAQ:RCEL
31
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
eGain
NAQ:EGAN
88
CountryUSA
IndustrySoftware
SizeSmall
Full Stock Analysis →
Five9
NMQ:FIVN
85
CountryUSA
IndustrySoftware
SizeMedium
Full Stock Analysis →
Box
NYQ:BOX
60
CountryUSA
IndustrySoftware
SizeLarge
Full Stock Analysis →
Intuit
NSQ:INTU
98
CountryUSA
IndustrySoftware
SizeX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →